Limouze John, Straight Aaron F, Mitchison Timothy, Sellers James R
Laboratory of Molecular Cardiology, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
J Muscle Res Cell Motil. 2004;25(4-5):337-41. doi: 10.1007/s10974-004-6060-7.
Blebbistatin is a small molecule inhibitor discovered in a screen for inhibitors of nonmuscle myosin IIA. We have examined the specificity and potency of the drug by assaying its effects on the actin-activated MgATPase assay of diverse members of the myosin superfamily. Blebbistatin potently inhibits several striated muscle myosins as well as vertebrate nonmuscle myosin IIA and IIB with IC50 values ranging from 0.5 to 5 microM. Interestingly, smooth muscle which is highly homologous to vertebrate nonmuscle myosin is only poorly inhibited (IC50=80 microM). The drug potently inhibits Dictyostelium myosin II, but poorly inhibits Acanthamoeba myosin II. Blebbistatin did not inhibit representative myosin superfamily members from classes I, V, and X.
肌球蛋白抑制剂是在筛选非肌肉肌球蛋白IIA抑制剂时发现的一种小分子抑制剂。我们通过检测其对肌球蛋白超家族不同成员的肌动蛋白激活的MgATP酶活性的影响,研究了该药物的特异性和效力。肌球蛋白抑制剂能有效抑制几种横纹肌肌球蛋白以及脊椎动物非肌肉肌球蛋白IIA和IIB,IC50值在0.5至5微摩尔之间。有趣的是,与脊椎动物非肌肉肌球蛋白高度同源的平滑肌仅受到微弱抑制(IC50 = 80微摩尔)。该药物能有效抑制盘基网柄菌肌球蛋白II,但对棘阿米巴肌球蛋白II的抑制作用较弱。肌球蛋白抑制剂不抑制I、V和X类的代表性肌球蛋白超家族成员。